Dual mechanisms of Vitisin A in managing alcoholic liver disease: Inhibition of lipogenesis and complement activation
Food and Chemical Toxicology · 2025
DOI: 10.1016/j.fct.2025.115639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2025. Verfasst von Yuanqin Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Engineering, Institute of Science and Technology, Jinan University, 601 Huangpu Road, Guangzhou, 510632, China. Hauptthemen laut MEDLINE: Anthocyanins, Complement Activation, Glucosides, Lipogenesis. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, Guangdong Provincial Department of Science and Technology.
Abstract (Originalsprache)
Pyranoanthocyanins in aged red wine show superior stability, pigmentation, antioxidative, anti-inflammatory, and hypocholesterolemic properties compared to unmodified anthocyanin precursors in vitro. However, evidence supporting their health benefits in vivo remains limited. This study evaluated the hepatoprotective effects of Vitisin A compared to Cyanidin-3-O-glucoside using Lieber-DeCarli mouse and AML12 cell models. Additionally, mulberry wine anthocyanins and their aged counterparts were evaluated in vivo. All anthocyanin treatments significantly alleviated ethanol-induced hepatic steatosis and improved alcohol metabolism. Notably, Vitisin A markedly reduced plasma AST and ALT levels (p < 0.05), a result not observed with C3G. RNA-seq analysis showed Vitisin A induced significant gene expression changes, especially in complement system and lipid metabolism pathways. It inhibited fatty acid synthesis by upregulating p-AMPK/AMPK and p-ACC/ACC ratios, suppressing FASN expression, and reduced complement activation by downregulating C3 and decreasing C3ar1 and Tnf-α expression, mitigating Kupffer cell-mediated inflammation. In contrast, C3G and ACNS had limited effects on these pathways, particularly in complement modulation. These findings highlight the dual actions of vitisin A in inhibiting de novo lipogenesis and complement activation, demonstrating its superior efficacy over C3G. This study underscores the therapeutic potential of vitisin A as a functional food component for managing alcoholic liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Engineering, Institute of Science and Technology, Jinan University, 601 Huangpu Road, Guangzhou, 510632, China.
- Department of Food Science and Engineering, Institute of Science and Technology, Jinan University, 601 Huangpu Road, Guangzhou, 510632, China. Electronic address: tjiaorui@jnu.edu.cn.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
- Guangdong Provincial Department of Science and Technology
Zitieren
APA
Zhu, Y., Deng, H., Liu, J., Li, X., Huang, X., Che, Z., Bai, W., & Jiao, R. (2025). Dual mechanisms of Vitisin A in managing alcoholic liver disease: Inhibition of lipogenesis and complement activation. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2025.115639
Vancouver
Zhu Y, Deng H, Liu J, Li X, Huang X, Che Z, et al. Dual mechanisms of Vitisin A in managing alcoholic liver disease: Inhibition of lipogenesis and complement activation. Food and Chemical Toxicology. 2025. doi:10.1016/j.fct.2025.115639
BibTeX
@article{Zhu2025,
author = {Zhu, Yuanqin and Deng, Huilin and Liu, Jia and Li, Xusheng and Huang, Xin and Che, Zhaodi and Bai, Weibin and Jiao, Rui},
title = {Dual mechanisms of Vitisin A in managing alcoholic liver disease: Inhibition of lipogenesis and complement activation},
journal = {Food and Chemical Toxicology},
year = {2025},
doi = {10.1016/j.fct.2025.115639}
}
EUVIMED